bioRxiv Science⌕ Search

Biology subjects

Martinez, K. L.

Publications and source records attributed to Martinez, K. L..

3 recordsLinked to original sources

Quantitative Determination of Protein Concentration in Living Cells

Biological systems are regulated by molecular interactions which are tuned by the concentrations of each of the molecules involved. Cells exploit this feature by regulating protein expression, to adapt their responses to overstimulation. Correlating events in single cells to the concentrations of proteins involved can therefore provide important mechanistic insight into cell behavior. Unfortunately, quantification of molecular densities by fluorescence imaging becomes non-trivial due to the diffraction limited resolution of the imaged volume. We show here an alternative approach to overcome this limitation in optical quantification of protein concentrations which is based on calibrating protein volume and surface densities in a model membrane system. We exploit the ability of fluorescently labeled annexin V to bind membranes in presence of calcium. By encapsulating known concentrations of annexin V, we can directly infer the membrane density of annexin V after addition of Ca2+ and correlate the density with the measured fluorescence signal. Our method, named Calmet, enables quantitative determination of the concentration of cytosolic and membrane associated proteins. The applicability of Calmet is demonstrated by quantification of a transmembrane protein receptor (beta 1 adrenergic receptor) labeled by SNAP tagged fluorophores and expressed in HEK293 cells. Calmet is a generic method suitable for the determination of a broad range of concentrations and densities and can be used on regular fluorescence images captured by confocal laser scanning microscopy.

biophysics↗

Suitable use of FRET-based Biosensors for Quantitative Detection of GPCR Activation

Cyclic adenosine 3,5-monophosphate is an important second messenger molecule that regulates many downstream signaling pathways in cells. Detection of cAMP levels relies on screenings of cell lysates or the use of genetically encoded biosensors for detection in living cells. Genetically encoded biosensors are, however, primarily used for bioimaging and rarely in high-throughput screenings of potential drug candidates. Here, we describe a quantitative fluorescence-based imaging method based on measurements of single living cells. We used a genetically encoded Epac149 biosensor to investigate cAMP production in living cells following ligand stimulation. The study revealed a dependence of the measured cAMP levels on the expression level of the biosensor in transiently transfected cells. While the biosensor maintained linearity of the signal at high expression levels, the linearity of the biosensor was lost at lower expression levels due to a deficit of the biosensor compared to the maximum possible production of cAMP in the cells. This problem was circumvented by establishment of a stable cell line with constitutive expression of the biosensor. We established dose response curves by stimulation with the {beta}1-adrenergic receptor partial agonist denopamine and observed up to 1.48-fold difference in the cellular response as well as up to 4.27-fold difference in LogEC50 values between cells with insufficient and sufficient biosensor expression. Careful characterization and control of the biosensor expression is therefore important in order to conduct quantitative analysis of the cAMP production and it allows the use of genetically encoded biosensor to be applied in high-throughput screenings.

biophysics↗

A photoswitchable ligand targeting β1-adrenoceptor enables light-control of the cardiac rhythm

Catecholamine-triggered {beta}-adrenoceptor ({beta}-AR) signaling is essential for the correct functioning of the heart. Although both {beta}1- and {beta}2-AR subtypes are expressed in cardiomyocytes, drugs selectively targeting {beta}1-AR have proven this receptor as the main target for the therapeutic effects of beta blockers in heart. Here, we report a new strategy for the spatiotemporal control of {beta}1-AR activation by means of light-regulated drugs with a high level of {beta}1-/{beta}2-AR selectivity. All reported molecules allow for an efficient real time optical control of receptor function in vitro. Moreover, using confocal microscopy we demonstrate that the binding of our best hit, pAzo-2, can be reversibly photocontrolled. Strikingly, pAzo-2 also enables a dynamic cardiac rhythm management on alive zebrafish larvae using light, thus highlighting the therapeutic and research potential of the developed photoswitches. Overall, this work provides the first proof of precise control of the therapeutic target {beta}1-AR in native environments using light.

pharmacology and toxicology↗